A service of the U.S. National Institutes of Health Module 3: The Librarian’s Role in Advocating to Clinical Researchers.

Slides:



Advertisements
Similar presentations
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Advertisements

1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
ClinicalTrials.gov: A service of the U.S. National Institutes of Health This project has been funded in whole or in part with Federal funds from the National.
1 ClinicalTrials.gov Presented by: Suzanne O’Shea Baker & Daniels LLP
ClinicalTrials.gov and FDAAA for NIH Grantees NIH Regional Seminar - June 2014 Rebecca J. Williams, PharmD, MPH Assistant Director, ClinicalTrials.gov.
NIH Public Access Policy It’s not just a good idea; It’s the law!
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
NIH Public Access Policy What it means to OHSU Researchers Presented by: Andrew Hamilton Date: 10/22/2009.
NCI Clinical Trials Reporting Program CTRP User Meeting November 2, 2011 Gene Kraus CTRP Program Director.
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
FOCUS ON NLM RESOURCES: CLINICALTRIALS.GOV. WHAT IS A CLINICAL STUDY?  Research study using human subjects.  Volunteers may have a certain disease or.
NCIs Clinical Trials Reporting Program (CTRP) vs. Clinicaltrials.gov
ClinicalTrials.gov and FDAAA for NIH Extramural Grants Gwynne L. Jenkins, PhD, MPH Special Assistant to the Director Office of Extramural Programs, OER.
ClinicalTrials.gov Stephen Kiyoi
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
Clinical Trials Registry Susan Koenig, MPP&PA Director, Office of Compliance & Quality University of Missouri-Columbia School of Medicine Compliance &
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
NIH Public Access Policy What it means to OHSU Researchers Presented by: Andrew Hamilton Date: 3/18/2007.
ClinicalTrials.gov Anna Ripple National Library of Medicine Bethesda, Maryland MLA Presentation May 2006.
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Download date: 27 Sept 2010.
1 NIH Public Access Policy Policy on Enhancing Public Access to Archived Publications Resulting From NIH-Funded Research (Public Access Policy)
A service of the U.S. National Institutes of Health Module 1: Clinical Trials and Requirements for Registration and Results Reporting.
The Registration of Clinical Trials Deborah A. Zarin, M.D. Director, ClinicalTrials.gov May 2007.
11 February 2008NLM BOR WG on Clinical Trials1 Clinical Trials Registration and Results Reporting: Legislative Requirements Jerry Sheehan Assistant Director.
NATIONAL CLINICAL TRIAL (NCT) NUMBER Clinical Trials Management Office December 17, 2014.
Special Issues in FDA-Regulated Studies: The Good, the Bad, and the Ugly C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst VA Office of Research & Development.
International Human Subject Research Legal and Ethical Considerations for Investigators Theresa J. Colecchia, Esq. Associate General Counsel May 8, 2006.
 Presented By: NameTitleOffice PresentationTitle NIH Regional Seminar May 7, 2015 David Curren Special Assistant to the Office Director Officer of Policy.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
FDA AA - Title VIII Clinical Trial Databases Friday, 30 November 2007 MBC Sarah Doyle Larson Program Manager, Biomedical Regulatory Affairs Compliance.
New Faculty Orientation August 22, 2012 UAMS Research Support Center Director: Tom Wells (501)
Clinical Trial Administration Presented by: Jill Griffith and Shannon Condon.
©Sideview Ethical research publication: who’s responsibility is it? Liz Wager PhD Publications Consultant, Sideview
Driving Innovation to Market. Partnering with the Office of Intellectual Property and Industry Sponsored Research December 10, 2013 Tara A. Kamin, Esq.
Task Force on Design and Analysis Introduction to Clinical Research Course Outline Bruce Pihlstrom
Key Compliance Risks in Clinical Trials Kathleen Meriwether Principal, ERNST & YOUNG, LLP Fraud Investigation & Dispute Services.
24 September 2009National Academies - BRDI1 Research Data and Information: New Developments at NIH Jerry Sheehan Assistant Director for Policy Development.
 Presented By: NameTitleOffice PresentationTitle NIH Regional Seminar June 26, 2014 David Curren Special Assistant to the Office Director Officer of Policy.
ClinicalTrials.gov Results Reporting, Unique Evidence, and the Role of Medical Librarians SCR CONNECTions March 19, 2014.
CTRP User Call November 13, 2013 Gene Kraus CTRP Program Director.
Melissa McCarey, MPH Jefferson Clinical Research Institute (JCRI) Clinicaltrials.gov: What is it? What do I need to know?
Clinicaltrials.gov Laurie A. Lebo, Ph.D
Guidelines for Clinical Trial Registration.. Background. In 2005 the International Committee of Medical Journal Editors (ICMJE) announced that in order.
1 Session 2 Expanded Clinical Trials Registry Deborah A. Zarin, M.D. NLM Accomplishments Impact to Date Specific Data Element Issues.
A service of the U.S. National Institutes of Health Module 2: Searching and Interpreting Results Posted on ClinicalTrials.gov.
Research as defined by DHHS A systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable.
Ethical Considerations Dr. Richard Adanu Editor-in-Chief International Journal of Gynecology and Obstetrics (IJGO)
This study is funded by a contract from the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Cancer.
Certificates of Confidentiality:
Emily Ouellette, JD Assistant Director, Partners QI Program
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
Qualifying Clinical Trials Wendy McAtee – Research Compliance Manager
FDAAA Clinical Trial Disclosure Briefing for GCP/QA SIAC
ClinicalTrials.gov Requirements
Tulane University Office of Research Compliance
Clinicaltrials.gov Update
EudraVigilance.
ClinicalTrials.gov: An introduction
IRB Compliance Program PRS Administrator, Brian Brotzman
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Download date: 27 Sept 2010.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Clinicaltrials.gov Joel Thompson, PhD COM Research Update
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Content downloaded: September 2012.
ICTMS Communicating Trial Results to participants
ClinicalTrials.gov Registration & Reporting Requirements
IRB Compliance Program PRS Administrator, Brian Brotzman
Masoud Solaymani-Dodaran Iran University of Medical Sciences
ClinicalTrials.gov PRS – How to Register and Maintain a Record
ClinicalTrials.gov PRS – How to Register and Maintain a Record
Presentation transcript:

A service of the U.S. National Institutes of Health Module 3: The Librarian’s Role in Advocating to Clinical Researchers

Increased Requirements for Registration and Results Reporting Selective publication makes it difficult to determine the true value of a treatment Comparisons of published drug trials with unpublished trials or other available data have shown that the benefits of a number of drugs have been much overrated and the harms much underrated As a result, FDAAA law and ICMJE policy require clinical trial registration and results reporting to increase access to clinical trial data

Results Posting Rate of studies with results posted has significantly increased since the launch of the ClinicalTrials.gov results database in September 2008

“No Study Results Posted” Not subject to FDAAA requirements to submit results Still ongoing Completed, but still prior to deadline for results submission Results have been submitted, but not yet posted Delayed due to certification or request to extend the results submission deadline

Challenges in Submitting Results Lack of awareness of results submission requirements Results submission must be completed by someone familiar with the study and data and experienced with ClinicalTrials.gov tabular format

Librarians’ Role OpenAccess PMC ClinicalTrials.gov

Advocating to Clinical Researchers Interventional studies of FDA-approved drugs, biologics, and devices At least one site in the US Initiated after September 2007 or ongoing as of December 2007 Excludes Phase I drug and small feasibility device studies Which trials must submit results under FDAAA? Study “Sponsor” (IND/IDE holder) Trial Initiator – Funding recipient (Grant), Funder (Contract) Sponsor may designate Principal Investigator as Responsible Party Who must submit? (“Responsible Party”)

Advocating to Clinical Researchers (cont.) Within 1 year of trial completion (delays possible) When should results be reported? Modules: Participant flow, baseline characteristics, outcome measures, and adverse events What information should be provided? Notice of non-compliance Civil Monetary Penalties (up to $10,000/day) Withholding of NIH Grant Funds What are the potential penalties?

Advocating to Others Patients can use ClinicalTrials.gov find clinical trials and make informed decisions with their health care provider about whether to participate Health professionals and researchers can use the ClinicalTrials.gov results database and links to PubMed citations to find results information

Summary Outcome reporting and publication biases prompted laws and policies requiring clinical trial registration and results reporting ClinicalTrials.gov Results Database has increased every year since inception, but needs assistance from librarians to increase access to all clinical trial data Librarians play an important role in advocating, educating, and assisting clinical researchers with registration and results reporting requirements